Collecting and Storing Tissue Samples From Women With or Without Breast Cancer | National Cancer Institute (NCI) | NCT00899301 |
Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival | Institut Claudius Regaud | NCT01574170 |
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions | AIDS Malignancy Consortium | NCT02135419 |
Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer | Madison Vaccines Inc | NCT02499835 |
Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging | Boston Medical Center | NCT02510456 |
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies | Fred Hutchinson Cancer Research Center | NCT02706392 |
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging | National Cancer Institute (NCI) | NCT02773238 |
Cost Utility of Radical Surgery in Ovarian Cancer | Institut Claudius Regaud | NCT02854215 |
Evaluation of an Organized Consultation Return Home of Patients With a Cancer (CREDO) | Institut Claudius Regaud | NCT02857400 |
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery | National Cancer Institute (NCI) | NCT02881554 |
Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular Cancer | Assistance Publique - Hôpitaux de Paris | NCT02929082 |
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs | Taiho Pharmaceutical Co. Ltd. | NCT02943733 |
FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer | University of Wisconsin Madison | NCT03212170 |
Phase I/II Trial of Regorafenib Hydroxychloroquine and Entinostat in Metastatic Colorectal Cancer | Abramson Cancer Center of the University of Pennsylvania | NCT03215264 |
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer | University of Wisconsin Madison | NCT03232164 |
Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer | Merck Sharp & Dohme Corp. | NCT03260504 |
Patient Navigation in Cancer Survivorship at a Safety Net Institution | Boston Medical Center | NCT03271099 |
PSMA PET and MRI in Gynecological Cancers | University of Wisconsin Madison | NCT03302156 |
PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients | National Cancer Institute (NCI) | NCT03342378 |
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer | National Cancer Institute (NCI) | NCT03358563 |
A Study to Test Different Doses of BI 836880 Combined With BI 754091 in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours | Boehringer Ingelheim | NCT03468426 |
The Prevent Anal Cancer Self-Swab Study | Baylor College of Medicine | NCT03489707 |
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer | University of Wisconsin Madison | NCT03490292 |
Outcomes of Focal Therapies for Prostate Cancer | Weill Medical College of Cornell University | NCT03492424 |
Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer | National Cancer Institute (NCI) | NCT03505671 |
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy | Institut Claudius Regaud | NCT03514368 |
Defining the Molecular Profile of Breast Cancer in Uganda and Its Clinical Implications | Fred Hutchinson Cancer Research Center | NCT03518242 |
Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer | AstraZeneca | NCT03570476 |
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer | AIQ Solutions | NCT03600350 |
The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane. | Institut Claudius Regaud | NCT03619044 |
A Prospective Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches | Weill Medical College of Cornell University | NCT03632655 |
Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS | National Cancer Institute (NCI) | NCT03703492 |
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer | Centre Leon Berard | NCT03721120 |
Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy | National Cancer Institute (NCI) | NCT03723863 |
Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas | Centre Leon Berard | NCT03732495 |
ONC201 With and Without Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer | The V Foundation for Cancer Research | NCT03733119 |
Cetuximab in Head and Neck Cancer Patients | American Cancer Society Inc. | NCT03769311 |
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases | National Cancer Institute (NCI) | NCT03796273 |
Medical Data Collection in the Formation of Precision Oncology Registry | National Cancer Institute (NCI) | NCT03874065 |
Study of IMMU-132 in HR+/HER2- MBC (TROPICS-02) | Immunomedics Inc. | NCT03901339 |
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced Recurrent Platinum Resistant Ovarian Fallopian Tube or Primary Peritoneal Cancer | Fred Hutchinson Cancer Research Center | NCT03907527 |
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients | University of Wisconsin Madison | NCT03933813 |
Platino-resistance in Ovarian Cancer | Institut Claudius Regaud | NCT03954171 |
Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer | Institut Claudius Regaud | NCT03956459 |
Deciphering Mechanisms Underlying Cancer Immunogenicity | Institut Claudius Regaud | NCT03958240 |
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy | National Cancer Institute (NCI) | NCT03958747 |
A Study of Sacituzumab Govitecan in Metastatic Solid Tumors (TROPICS-03) | Immunomedics Inc. | NCT03964727 |
A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection. | Institut Claudius Regaud | NCT03986437 |
AREG EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer | Newcastle University | NCT03986541 |
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients | National Cancer Institute (NCI) | NCT03987555 |
Characterize Tumor Hypoxia by Magnetic Resonance Imaging | National Cancer Institute (NCI) | NCT03987568 |
Metabolic and Microbial Profiling of Lung Cancer | National Cancer Institute (NCI) | NCT03998189 |
Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis | National Cancer Institute (NCI) | NCT04040244 |
The Prevent Anal Cancer Palpation Study | Baylor College of Medicine | NCT04090060 |
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant Metastatic Prostate Cancer | Madison Vaccines Inc | NCT04090528 |
Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy | KeraNetics LLC | NCT04173247 |
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer | University of Wisconsin Madison | NCT04174352 |
Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors | Breast Cancer Research Foundation | NCT04200482 |
E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer. | Institut Claudius Regaud | NCT04228432 |
Prevalence and Impact on QoL From Ototoxicity in Cancer Survivors | International Stem Cell Forum | NCT04270916 |
LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+) | UNC Lineberger Comprehensive Cancer Center | NCT04292847 |